{"id":104151,"date":"2026-06-26T02:32:42","date_gmt":"2026-06-26T02:32:42","guid":{"rendered":"https:\/\/www.europesays.com\/canada\/104151\/"},"modified":"2026-06-26T02:32:42","modified_gmt":"2026-06-26T02:32:42","slug":"beyond-the-actual-invention-a-closer-look-at-canadas-2026-updated-subject-matter-framework-compared-with-u-s-practice","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/canada\/104151\/","title":{"rendered":"Beyond the &#8216;Actual Invention&#8217;: A Closer Look at Canada&#8217;s 2026 Updated Subject Matter Framework Compared with U.S. Practice"},"content":{"rendered":"<p>\u201cPatentable subject matter is increasingly becoming a front-end strategic consideration rather than one left for prosecution.\u201d<\/p>\n<p><a href=\"https:\/\/depositphotos.com\/photo\/futuristic-hand-robot-pointing-lightbulb-representing-concepts-artificial-intelligence-robotics-667872462.html\" rel=\"nofollow noopener\" target=\"_blank\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-202927 alignright\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Depositphotos_667872462_S.jpg\" alt=\"subject matter\" width=\"506\" height=\"238\"  \/><\/a>The Canadian Intellectual Property Office (CIPO) has materially changed how examiners are instructed to apply the law on patentable subject matter. In <a href=\"https:\/\/ised-isde.canada.ca\/site\/canadian-intellectual-property-office\/en\/march-2026-practice-notice-patentable-subject-matter-under-patent-act\" rel=\"nofollow noopener\" target=\"_blank\">March 2026<\/a>, CIPO replaced its <a href=\"https:\/\/ised-isde.canada.ca\/site\/canadian-intellectual-property-office\/en\/patentable-subject-matter-under-patent-act\" rel=\"nofollow noopener\" target=\"_blank\">November 2020<\/a> practice notice on computer-implemented inventions, medical diagnostic methods, and medical uses. The 2026 notice represents an important development for current Canadian prosecution practice.<\/p>\n<p>The 2026 notice incorporates a framework shift and catches up with several court decisions that have recently interpreted the underlying law. CIPO has folded the \u201cactual invention\u201d inquiry into purposive construction, rather than treating it as a separate analytical step, and continues to organize Canadian subject-matter analysis around a physicality requirement anchored in subsection 27(8) of the Patent Act. <a href=\"https:\/\/canlii.ca\/t\/kgfwd\" rel=\"nofollow noopener\" target=\"_blank\">Dusome<\/a>, which concerned a method for playing a card game either physically or on a computer, was a major driver of this recent practice notice. Consistent with Dusome, the notice moves the \u201cactual invention\u201d inquiry back into purposive construction, expressly disapplies MOPOP\u2019s guidance relating to games, and formalizes the <a href=\"https:\/\/canlii.ca\/t\/jqwkb\" rel=\"nofollow noopener\" target=\"_blank\">Schlumberger<\/a> question for computer-implemented claims that lack physicality beyond the computer system itself.<\/p>\n<p>Overall, Canada continues to maintain a relatively restrictive approach for software, artificial intelligence (AI), and medical-use claims, though Canadian diagnostics practice is generally more permissive than U.S. practice. The approach to medical uses may evolve, as the Supreme Court of Canada is considering the appeal in <a href=\"https:\/\/canlii.ca\/t\/k2w4n\" rel=\"nofollow noopener\" target=\"_blank\">Pharmascience<\/a>. This highly awaited decision is expected to provide further guidance on what constitutes a method of medical treatment.<\/p>\n<p>For patentable subject matter, the USPTO continues to apply the Alice\/Mayo framework set out in MPEP \u00a7 2106 (Alice Corp v. CLS Bank International, <a href=\"https:\/\/tile.loc.gov\/storage-services\/service\/ll\/usrep\/usrep573\/usrep573208\/usrep573208.pdf\" rel=\"nofollow noopener\" target=\"_blank\">573 U.S. 208 (2014)<\/a>; Mayo Collaborative Services v Prometheus Labs., <a href=\"https:\/\/tile.loc.gov\/storage-services\/service\/ll\/usrep\/usrep566\/usrep566066\/usrep566066.pdf\" rel=\"nofollow noopener\" target=\"_blank\">566 U.S. 66 (2012)<\/a>). Separate memoranda addressing AI and recent examination practice supplement the framework rather than replace it. These updates instruct examiners to resolve close eligibility calls in favor of the applicant (<a href=\"https:\/\/www.uspto.gov\/sites\/default\/files\/documents\/memo-101-20250804.pdf\" rel=\"nofollow noopener\" target=\"_blank\">August 4, 2025<\/a>), encourage the use of subject matter eligibility declarations to overcome rejections under 35 U.S.C. \u00a7 101 through objective evidence of eligibility (<a href=\"https:\/\/www.uspto.gov\/sites\/default\/files\/documents\/smeds-corps.pdf\" rel=\"nofollow noopener\" target=\"_blank\">December 4, 2025<\/a>), and expand the concept of qualifying improvements beyond computer functionality to include improvements to a technology or technical field (<a href=\"https:\/\/www.uspto.gov\/web\/offices\/pac\/mpep\/ANC-Desjardins-Memo-12-5-25.pdf\" rel=\"nofollow noopener\" target=\"_blank\">December 5, 2025<\/a>).<\/p>\n<p>CIPO\u2019s developments are of particular interest to practitioners managing global patent portfolios, including parallel U.S. and Canadian applications, as they highlight both the similarities and differences in the subject matter eligibility frameworks applied in each jurisdiction for computer implemented inventions. Understanding these distinctions can be important when coordinating cross-border drafting, filing, and prosecution strategies.<\/p>\n<p>A detailed comparison table at the end of this article summarizes Canada\u2019s prior framework, Canada\u2019s updated approach, and U.S. practice across key subject matter categories.<\/p>\n<p>In short, while both jurisdictions share similar concerns about abstract claims and generic computer use, Canada\u2019s physicality-based framework and the U.S. Alice\/Mayo framework can lead to different outcomes\u2014making early attention to cross-border drafting considerations increasingly important.<\/p>\n<p>Key Takeaways<\/p>\n<p>While CIPO\u2019s 2026 Practice Notice refines, rather than replaces, Canada\u2019s existing approach to patentable subject matter, it does provide important insight into how patentable subject matter should be assessed by Canadian Examiners. Key changes include:<\/p>\n<p>No standalone \u201cactual invention\u201d analysis: This analysis has been folded into purposive construction.<br \/>\nPhysicality remains central: Physical existence or a discernible physical effect continues to underpin patent eligibility analysis.<br \/>\nThe Schlumberger question is now explicit: Where a computer is the only physical element, examiners are directed to assess whether the claimed contribution extends beyond the mere use of a computer.<br \/>\nCommon general knowledge matters more: Conventional or sparsely described features may receive less weight in the analysis.<br \/>\nThe practical impact remains to be seen: As examination guidance rather than binding law, its significance will ultimately depend on examination practice and future judicial consideration.<\/p>\n<p>Patent Eligibility Starts at Drafting<\/p>\n<p>If Canada is on your filing horizon, now is the time to rethink your drafting playbook. Under the 2026 guidance, patentable subject matter may increasingly need to be addressed at the drafting stage\u2014not only during prosecution. Here\u2019s how to mitigate eligibility risk from the outset:<\/p>\n<p>Ground the invention in tangible terms. Explain how the claimed method engages with hardware, what physical effects flow from it, and why the implementation goes beyond routine steps on a generic computer.<br \/>\nHighlight physicality. Emphasize hardware interactions, measurements, sensors, or improvements to computer functionality wherever supported by the disclosure.<br \/>\nCaution conventionality. Features characterized as \u201cwell-known\u201d or \u201croutine\u201d may carry less weight in the eligibility analysis\u2014describe them with care.<br \/>\nLayer your claims. Include fallback positions anchored in non-computer physical elements and demonstrable computational improvements.<br \/>\nDraft with Canada in mind. A specification optimized solely for U.S. practice may not provide the strongest foundation for Canadian eligibility.<\/p>\n<p>A Growing Need for Cross-Border Alignment<\/p>\n<p>As the table below illustrates, a claim set that feels comfortable under U.S. practice may need a slightly different drafting style in Canada. Canadian and U.S. approaches still align in many respects, with Examiners appearing to review counterpart prosecution when examining cases, but they diverge in others, such as medical diagnostic methods. Coordinated drafting and prosecution planning across jurisdictions may become increasingly important for global portfolio management.<\/p>\n<p>Looking Ahead<\/p>\n<p style=\"text-align: left;\">The full impact of the 2026 guidance will emerge through examination practice and future judicial decisions, but one point is becoming clear: patentable subject matter is increasingly becoming a front-end strategic consideration rather than one left for prosecution. For applicants seeking Canadian patent protection for software, AI, fintech, and other computer-implemented technologies, early drafting decisions may significantly affect claim scope, prosecution flexibility, and long-term portfolio value.<\/p>\n<p><a href=\"https:\/\/ipwatchdog.com\/wp-content\/uploads\/2026\/06\/US-CA-Eligibility-Table-Comparison95404540.11.docx\" rel=\"nofollow noopener\" target=\"_blank\">See chart with hyperlinks here.\u00a0<\/a><\/p>\n<p><a href=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.17-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-202953 aligncenter\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.17-AM.png\" alt=\"\" width=\"1008\" height=\"1298\"  \/><\/a> <a href=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.32-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-202954 aligncenter\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.32-AM.png\" alt=\"\" width=\"1002\" height=\"1300\"  \/><\/a> <a href=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.44-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-202955 aligncenter\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.44-AM.png\" alt=\"\" width=\"1002\" height=\"1240\"  \/><\/a> <a href=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.58-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-202956 aligncenter\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.32.58-AM.png\" alt=\"\" width=\"998\" height=\"1290\"  \/><\/a> <a href=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.33.08-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-202957 aligncenter\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-25-at-11.33.08-AM.png\" alt=\"\" width=\"998\" height=\"1106\"  \/><\/a><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>    <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Shahzrad-Esmali-e1782313054919.webp\" alt=\"Shahrzad Esmaili image\" width=\"90\" height=\"90\"\/><\/p>\n<p>        <a href=\"https:\/\/ipwatchdog.com\/author\/shahrzad-esmaili\/\" rel=\"nofollow noopener\" target=\"_blank\">Shahrzad Esmaili<\/a><\/p>\n<p>        Shahrzad Esmaili is an IP partner at Gowling WLG (Canada) LLP in Toronto. As a seasoned patent practitioner, she advises technology companies, research institutions, and international associates on Canadian patent\u00a0<a href=\"https:\/\/ipwatchdog.com\/author\/shahrzad-esmaili\/\" rel=\"nofollow noopener\" target=\"_blank\">[&#8230;see more]<\/a><\/p>\n<p>    <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/James-Longwell-e1782315779167.webp\" alt=\"Shahrzad Esmaili image\" width=\"90\" height=\"90\"\/><\/p>\n<p>        <a href=\"https:\/\/ipwatchdog.com\/author\/james-longwell\/\" rel=\"nofollow noopener\" target=\"_blank\">James Longwell<\/a><\/p>\n<p>        James Longwell is a partner and a past leader of Gowling WLG\u2019s Patents Group. Jim practices in all areas of IP law, particularly as it applies to computer and information\u00a0<a href=\"https:\/\/ipwatchdog.com\/author\/james-longwell\/\" rel=\"nofollow noopener\" target=\"_blank\">[&#8230;see more]<\/a><\/p>\n<p>    <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/canada\/wp-content\/uploads\/2026\/06\/Adam-Mausnell-e1782315442922.png\" alt=\"Shahrzad Esmaili image\" width=\"90\" height=\"90\"\/><\/p>\n<p>        <a href=\"https:\/\/ipwatchdog.com\/author\/adam-maunsell\/\" rel=\"nofollow noopener\" target=\"_blank\">Adam Maunsell<\/a><\/p>\n<p>        Adam Maunsell is an articling student in Gowling WLG\u2019s Toronto office. He completed his JD at Western University. During law school, Adam was the acting student director for the Western\u00a0<a href=\"https:\/\/ipwatchdog.com\/author\/adam-maunsell\/\" rel=\"nofollow noopener\" target=\"_blank\">[&#8230;see more]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"\u201cPatentable subject matter is increasingly becoming a front-end strategic consideration rather than one left for prosecution.\u201d The Canadian&hellip;\n","protected":false},"author":2,"featured_media":104152,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[439,17,37373,37374,3042,3518,37375,37376,37377,37378],"class_list":["post-104151","post","type-post","status-publish","format-standard","has-post-thumbnail","category-canada","tag-artificial-intelligence","tag-canada","tag-canadian-intellectual-property-office","tag-guest-contributor","tag-innovation","tag-intellectual-property","tag-patent","tag-patent-eligibility","tag-patent-eligible","tag-patentable-subject-matter"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/104151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/comments?post=104151"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/104151\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media\/104152"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media?parent=104151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/categories?post=104151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/tags?post=104151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}